Sharpe J Danielle, Laws Rebecca L, West Christine A, Djomand Gaston, Omolo Jared, Ramaabya Dinah, Li Michelle, Dlamini Sindisiwe, Motebang Maletsatsi, Marake Nthuseng, Singano Victor, Ozituosauka Washington, McCabe Carter, Sathane Isabel, Kancheya Nzali, Chisenga Tina, Malaba Rickie, Ncube Getrude, Philip Neena M, Biraro Samuel, Charurat Man E, Rolle Italia, Voetsch Andrew C
Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
J Int AIDS Soc. 2025 Jun;28(6):e26446. doi: 10.1002/jia2.26446.
HIV pre-exposure prophylaxis (PrEP) is an effective biomedical intervention for preventing HIV; however, PrEP adoption initially lagged across sub-Saharan Africa (SSA) and may have been affected by barriers to engagement in PrEP care. Stable, heterosexual HIV-serodifferent couples are a priority population of PrEP expansion efforts. We assessed factors associated with PrEP awareness and willingness among HIV-serodifferent couples in SSA to guide PrEP interventions for this population.
We conducted a cross-sectional analysis using pooled data from nationally representative, two-stage cluster sampling, HIV-focused household surveys completed during 2019-2022 in seven African countries. We analysed data from 1738 persons without HIV aged ≥15 years in stable, heterosexual HIV-serodifferent couples and included clinical information from their partners with HIV. Higher HIV risk was defined by unawareness of a partner's HIV-positive status or having a partner with an unsuppressed viral load (≥200 copies/ml). Lower HIV risk was defined by awareness of a partner's HIV-positive status and having a partner with a suppressed viral load (<200 copies/ml). We conducted multivariable logistic regression using survey weights and jackknife variance estimation to assess factors associated with PrEP awareness and willingness.
Overall, 18.1% were aware of PrEP, 69.1% were willing to use PrEP and 5.1% had ever used PrEP. Forty-four percent had higher HIV risk. Higher odds of PrEP awareness were associated with being female (adjusted odds ratio [aOR]: 1.73; 95% confidence interval [CI]: 1.15-2.59), secondary education or higher (aOR: 6.42; 95% CI: 2.97-13.91) and lower HIV risk (aOR: 1.58; 95% CI: 1.00-2.48). Higher odds of PrEP willingness were associated with employment in the past year (aOR: 1.55; 95% CI: 1.01-2.37), previous PrEP awareness (aOR: 2.44; 95% CI: 1.36-4.36) and lower HIV risk (aOR: 1.70; 95% CI: 1.07-2.70).
Persons in stable, heterosexual HIV-serodifferent couples with lower HIV risk were more aware of and willing to use PrEP than those with higher risk. Our findings highlight the importance of encouraging HIV status disclosure, educating about HIV-serodifference and PrEP, and providing PrEP linkage during HIV testing and prevention counselling to increase PrEP awareness, willingness and use among HIV-serodifferent couples in SSA.
HIV暴露前预防(PrEP)是预防HIV的一种有效生物医学干预措施;然而,PrEP在撒哈拉以南非洲(SSA)的采用率最初较低,可能受到PrEP护理参与障碍的影响。稳定的异性恋HIV血清学不同伴侣是PrEP推广工作的重点人群。我们评估了SSA中HIV血清学不同伴侣对PrEP的知晓情况及意愿的相关因素,以指导针对该人群的PrEP干预措施。
我们使用2019 - 2022年期间在七个非洲国家完成的具有全国代表性的两阶段整群抽样、以HIV为重点的家庭调查汇总数据进行横断面分析。我们分析了1738名年龄≥15岁、处于稳定异性恋HIV血清学不同伴侣关系且未感染HIV者的数据,并纳入了其感染HIV伴侣的临床信息。较高的HIV风险定义为不知伴侣的HIV阳性状态或伴侣病毒载量未得到抑制(≥200拷贝/毫升)。较低的HIV风险定义为知晓伴侣的HIV阳性状态且伴侣病毒载量得到抑制(<200拷贝/毫升)。我们使用调查权重和刀切法方差估计进行多变量逻辑回归,以评估与PrEP知晓情况及意愿相关的因素。
总体而言,18.1%的人知晓PrEP,69.1%的人愿意使用PrEP,5.1%的人曾使用过PrEP。44%的人有较高的HIV风险。PrEP知晓率较高与女性(调整后的优势比[aOR]:1.73;95%置信区间[CI]:1.15 - 2.59)、接受过中等及以上教育(aOR:6.42;95% CI:2.97 - 13.91)以及较低的HIV风险(aOR:1.58;95% CI:1.00 - 2.48)相关。PrEP意愿较高与过去一年有工作(aOR:1.55;95% CI:1.01 - 2.37)、之前知晓PrEP(aOR:2.44;95% CI:1.36 - 4.36)以及较低的HIV风险(aOR:1.70;95% CI:1.07 - 2.70)相关。
HIV血清学不同的稳定异性恋伴侣中,HIV风险较低者比风险较高者更知晓且更愿意使用PrEP。我们的研究结果强调了鼓励披露HIV感染状况、开展关于HIV血清学差异和PrEP的教育,以及在HIV检测和预防咨询期间提供PrEP转介服务对于提高SSA中HIV血清学不同伴侣对PrEP的知晓率、意愿及使用率的重要性。